Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Norway's benchmark Oslo OBX finished higher on Tuesday, climbing 0.36% as gains in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities supported the market. Cmb.Tech NV led the index's winners and reached a 52-week high, while Nel ASA and other names declined. Commodity and currency markets moved alongside equities, with c…
Israel’s main equity gauge, the TA-35, closed slightly higher Tuesday, reaching a new all-time peak. Gains in biomedical, technology and banking names supported the advance, while a larger number of issues declined than rose. Selected commodities and currency benchmarks moved modestly, with crude and Brent oil up and the US Dollar Index futures low…
Aumovio SE announced plans to eliminate as many as 4,000 research and development positions worldwide as part of a cost-control plan in a challenging market environment. The company said the reductions will be mostly complete by the end of 2026 and will include a voluntary redundancy program in Germany beginning in March. The move accompanies a tar…
MicroVision Inc said it won a bankruptcy-auction bid to acquire certain Luminar Technologies assets for $33 million in cash, a move that lifted its stock by about 4% on Tuesday. The purchase includes intellectual property and inventory tied to the Iris and Halo lidar sensors, select engineering and operations personnel, and specific commercial cont…
Greek equities closed higher on Tuesday, with the Athens General Composite advancing 1.49% to reach a new five-year high. Gains were concentrated in the Banking, Construction and Travel sectors, while retail and telecom names underperformed. Market breadth remained narrow, with slightly more decliners than advancers and a meaningful move in commodi…
SentinelOne (NYSE: S) saw its stock rise roughly 1% after Citron Research published a bullish note arguing the cybersecurity company is well-positioned to protect against risks posed by autonomous AI agents. Citron pointed to SentinelOne’s acquisition of Prompt Security and described the technology as a governance layer for agentic systems that can…
TD Cowen has begun coverage of Intuitive Surgical with a Buy rating and a $660 price target, arguing the da Vinci 5 launch will create a prolonged product cycle. The firm expects both growth in installed fleets and replacement-led redeployment of prior-generation systems into price-sensitive markets, which it believes will broaden access and lift o…
SK Telecom shares climbed sharply after investors recalibrated the worth of the company’s 2023 investment in AI developer Anthropic. The stock gained 12% to reach $26.93, clearing its prior 52-week peak, as analysts and market participants assessed the possible valuation uplift from Anthropic’s rising implied worth and the implications for sharehol…
Morgan Stanley reaffirmed an Equalweight rating and an $81 price target on Arrowhead Pharmaceuticals (ARWR), signaling roughly 19% upside from the current share price of $67.94. The bank highlighted ongoing progress in the ARO-DIMER-PA program and reiterated that Phase 3 SHASTA-3/4 studies of Redemplo (plozasiran) remain the primary 2026 catalyst f…
Citi has initiated comprehensive coverage of major European pharmaceutical companies, assigning Buy ratings to AstraZeneca and Novartis and Neutral ratings to GSK, Novo Nordisk and Sanofi. Analyst Graham Parry highlighted valuation, pipeline robustness and looming loss-of-exclusivity events as the principal factors shaping the bank's relative prefe…
Omeros Corporation's stock edged up after the company said it has completed first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors and that transplant centers are beginning to place orders. The therapy, approved by the FDA for adults and children aged two and above, is now being administered to both adult and pediatric patients …
Tesla’s stock is consolidating near $435 after a mild pullback, with momentum still soft but not broken. The market is paying a steep price for future software-like economics, and the TAAS narrative is the clearest path to justify that valuation. This trade idea looks for a reclaim of near-term trend levels with a tight stop, aiming for a push back…
Retail investors in the United States have driven unusually large flows into silver exchange-traded funds, with one-day net purchases of the iShares Silver Trust far exceeding past peaks. Vanda Research reported that individual investors bought about $171 million of the fund on Monday, a level nearly double the prior one-day high seen during the 20…
Kepler Cheuvreux has published a sector review of European capital goods, screening 75 companies with market capitalizations above EUR2 billion to identify preferred and least preferred names for 2026. The research highlights concentrated growth in the US and India, strength in data centers and infrastructure-related markets, and mixed prospects ac…
Federal suspension of financing for a $17.2 billion Hudson River tunnel project means crews will halt work on Feb. 6 unless the Trump administration reverses its decision, a New Jersey congressman said. The tunnel, a replacement for infrastructure damaged in 2012, links New York City and New Jersey and serves a region responsible for 10% of U.S. ec…
Roth/MKM raised its price target for Alphabet to $365 from $310 and left its Buy rating intact ahead of Alphabet’s fourth-quarter earnings. The firm highlighted multiple potential catalysts in the first half of 2026 - including TPU chip partnerships, Waymo city launches, progress on the Gemini app and likely news around Gemini 4.0 - while noting th…
UBS raised its price target on Teck Resources to C$90 from C$80 and kept a Buy rating, pointing to the company’s copper-heavy earnings mix, expected production increases through 2030 and a solid liquidity position. The firm highlights valuation upside relative to peers even after recent share gains. The proposed merger with Anglo American remains a…
TD Cowen raised its price target for Cardinal Health to $233 from $225 and affirmed a Buy rating, pointing to an increased guidance above $10 per share and what it views as largely de-risked fiscal second-quarter results. The stock trades below the new target and near its 52-week high, while several analysts have nudged up fiscal 2026 EPS estimates…
TD Cowen has reaffirmed a Sell rating and a $70 price target on Roblox Corp. after its January 2026 parent survey showed an increase in parents imposing time and spending limits on the platform. The research house warned these restrictions could pressure engagement metrics. Roblox shares are trading near $72.53, and the company is due to report ear…
Truist Securities has reiterated a Buy rating on Cytokinetics with an $84.00 price target — implying roughly 28% upside from the stock's prevailing price of $65.64. The firm points to growing clinical preference for Myqorzo (aficamten) versus Bristol Myers Squibb's Camzyos among new hypertrophic cardiomyopathy patient starts, and it says positive k…
Freedom Capital Markets raised its rating on Netflix from Hold to Buy even as it slashed the firm’s price target to $104 from $1,070. The action comes after Netflix reported Q4 FY2025 results that beat consensus across key metrics, including subscriber expansion and advertising growth, but management issued cautious forward guidance and signaled hi…
TD Cowen raised its price objective on Option Care Health to $37 from $27 and kept a Hold rating, citing the company’s preliminary 2026 guidance and stronger-than-expected adjusted EBITDA outlook. Other brokerages have also adjusted targets and ratings following preliminary fourth-quarter results and updated cash-flow forecasts tied to strategic in…
TD Cowen has increased its price target for BrightSpring Health (BTSG) to $46 from $42 while keeping a Buy rating, pointing to continued fourth-quarter momentum driven by specialty oncology generics, a ramp in Limited Distribution Drugs, and improved Infusion segment performance. The firm projects adjusted EBITDA of $188 million for the quarter ver…
Trading on Tuesday produced sharp moves across market-cap bands, with large healthcare insurers among the weakest names after policy news and a mix of gains in semiconductors, cloud and data center-related stocks. Mega-cap losses included UnitedHealth, while Humana and CVS were large-cap decliners. A range of mid- and small-cap companies also recor…
Citigroup has enacted a broad reshuffle of its corporate banking leadership under Vis Raghavan, the executive recruited from JPMorgan Chase. The changes install co-heads for corporate banking, name global chairs for investment and corporate banking, and reassign senior North American roles as the bank pursues improved returns under CEO Jane Fraser.
